天府锦城实验室（前沿医学中心）是由成都高新区与四川大学于2020年合作筹建，2022年6月经四川省委省政府批准后注册成立，2022年11月23日正式揭牌运行的新型研发事业单位。实验室以国家战略需求和人民生命健康为导向，以攻克“卡脖子”技术难题为发力点，以科技创新引领产业创新、培育和发展新质生产力为目标，重点针对恶性肿瘤、心脑血管与代谢性疾病、神经系统疾病等三类重大疾病，开展预防、诊断、治疗和康复等全流程药械开发，实现“0-1”的原始创新、“1-10”的创新转化，力争打造医疗健康领域的国家战略科技力量。
为加快推进四川省人力资源和社会保障标准化技术委员会（以下简称标委会）相关工作，标委会秘书处拟招聘编外专职工作人员1名，按照《厅属事业单位编外聘用人员聘用管理办法》规定，现公开招聘事项如下。
About the Laboratory
Tianfu Jincheng Laboratory (JC-lab) is an innovative research institution jointly founded by Sichuan University and the Chengdu High-tech Zone, under the leadership of the Sichuan Provincial Government. The laboratory is dedicated to addressing major medical challenges, with a strategic focus on cancer biology, cardiovascular and metabolic disorders, and neurological diseases. The investigators in the JC-lab carry out fundamental research (“from 0 to 1”) in understanding the disease mechanisms, and technological development with clinical translations in drug discovery, and precision diagnosis and therapy (“from 1 to 10”). The lab is striving to become a leading institution in China and the world in medical science and biotechnology.